Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PET Scan”

1,415 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,415 results

Not applicableLooking for participantsNCT06105411
What this trial is testing

Siderophore-labelled Positron Emission Tomography for Correlating Invasive Fungal InfeCtions

Who this might be right for
Invasive Fungal Infections
Peter MacCallum Cancer Centre, Australia 10
Not applicableLooking for participantsNCT07335900
What this trial is testing

A Clinical Study Using FAPI-PET Imaging to Assess the Postoperative Effects of TAVI in Patients With Aortic Stenosis

Who this might be right for
Severe Aortic Valve Stenosis
RenJi Hospital 25
Post-approval studies (Phase 4)Looking for participantsNCT05376878
What this trial is testing

An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Malignant Neoplasm in the Brain
City of Hope Medical Center 10
Testing effectiveness (Phase 2)Study completedNCT00181168
What this trial is testing

Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer

Who this might be right for
Thyroid Cancer
Johns Hopkins University 63
Early research (Phase 1)Looking for participantsNCT05629689
What this trial is testing

Evaluate GEH200520/GEH200521 (18F) Safety and Tolerability When Used for PET Scans in Patients With Solid Tumour Malignancies

Who this might be right for
Malignant Solid TumorOncology
GE Healthcare 50
Not applicableEnded earlyNCT04874818
What this trial is testing

CD8+ T-cell PET/CT Imaging in COVID-19 Patients

Who this might be right for
Lymphopenia Due to COVID-19T-cellPET Imaging
Radboud University Medical Center 5
Very early researchEnded earlyNCT03757910
What this trial is testing

Brain Imaging in the Diabetes Prevention Program Outcomes Study

Who this might be right for
Alzheimer Disease
José A. Luchsinger 5
Testing effectiveness (Phase 2)Looking for participantsNCT06904313
What this trial is testing

Ultralow Dose PET Imaging for PSMA Expression

Who this might be right for
Healthy VolunteerProstate CA
Akiva Mintz 200
Early research (Phase 1)Study completedNCT01826110
What this trial is testing

PET Imaging Study Using [11C]PIB in Subjects With AD & Healthy Volunteers

Who this might be right for
Alzheimer's Disease
Johns Hopkins University 21
Very early researchStudy completedNCT00743353
What this trial is testing

Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5

Who this might be right for
SarcomaMelanomaLung Cancer+2 more
Siemens Molecular Imaging 16
Testing effectiveness (Phase 2)UnknownNCT03951337
What this trial is testing

64Cu-ATSM PET/CT in Rectum Cancer (TEP 64Cu-ATSM-Rectum)

Who this might be right for
Rectal Cancer
Institut Cancerologie de l'Ouest 70
Early research (Phase 1)Study completedNCT05666687
What this trial is testing

An Open-label, Adaptive Design, Positron Emission Tomography Study in Healthy Male Participants to Characterize Receptor Occupancy by MIJ821 in the Brain

Who this might be right for
Major Depressive Disorder
Novartis Pharmaceuticals 10
Not applicableStudy completedNCT01963221
What this trial is testing

Relationship Between Thoracic Aortic Structure Assessed B PET/CT Scan and Arterial Stiffness in Elderly Patients

Who this might be right for
AgingInflammation
Central Hospital, Nancy, France 30
Very early researchUnknownNCT04841421
What this trial is testing

Clinical Study on PET Imaging, Distribution and PK of 89Zr-CD147 in Patients With Solid Tumors

Who this might be right for
Solid Tumor
Sinotau Pharmaceutical Group 30
Testing effectiveness (Phase 2)Enrolling By InvitationNCT05805839
What this trial is testing

Imaging in Demyelinating Diseases

Who this might be right for
Multiple SclerosisInflammatory Demyelinating Disease
Mayo Clinic 200
Not applicableStudy completedNCT06350903
What this trial is testing

Suppression With Empagliflozin as an Alternative To High-Fat Low-Carbohydrate Diet for Myocardial F-fluorodeoxyglucose Positron Emission Tomography (FDG-PET) Imaging

Who this might be right for
Myocardial Suppression
Matthieu Pelletier-Galarneau, MD MSc 16
Large-scale testing (Phase 3)Looking for participantsNCT05456503
What this trial is testing

PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-2620

Who this might be right for
Frontotemporal Lobar DegenerationAlzheimer DiseaseCognitively Normal
University of Pennsylvania 72
Not applicableUnknownNCT05803746
What this trial is testing

PD-L2 Targeting Nanobody Radiotracer for PET Imaging of Solid Tumor

Who this might be right for
Lung CancerColorectal Cancer
Peking University Cancer Hospital & Institute 20
Not applicableStudy completedNCT01879657
What this trial is testing

68Ga-DOTATATE PET-CT for Diagnosis of Neuroendocrine Tumors (NETs)

Who this might be right for
Neuroendocrine Carcinoma
Radio Isotope Therapy of America 169
Not applicableStudy completedNCT05522257
What this trial is testing

PSMA Expression and PSMA PET Imaging in Soft Tissue Sarcomas and Urothelial Cell Carcinomas

Who this might be right for
Sarcoma,Soft TissueUrothelial Carcinoma
Leiden University Medical Center 25
Next Page